Guardant Health EBIT

Guardant Health (GH) currently reports a EBIT of $-450M as of June 2026. That compares with $-430M in the prior-year period — down 5.7% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Guardant Health's EBIT history and peer comparisons.

Guardant Health's EBIT decreased from $-430M to $-450M — a 5.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Guardant Health's EBIT of $-450M is lower than the Healthcare sector average of $22B. That is roughly 102.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Guardant Health reported $-450M in EBIT as of June 2026. That compares with $-430M in the prior-year period — down 5.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-450M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Guardant Health, and consider following GH for alerts when major investors trade the stock.